Mirna Sequencing And Assay Market Report
First published: 14 October 2024 | Last updated: 28 May 2026 | Report Code: mirna-sequencing-and-assay
Mirna Sequencing And Assay Market — USD 1.5 billion in 2023, Growing to USD 4.03B by 2033 at 10% CAGR
This report presents a comprehensive analysis of the Mirna Sequencing and Assay market, providing valuable insights into market size, trends, and forecasts from 2023 to 2033, along with industry-specific challenges and opportunities.
Key Takeaways
- Global market value increases from $1.50 Billion in 2023 to $4.03 Billion in 2033, reflecting a 10% CAGR across 2023 to 2033.
- North America holds the largest regional share, moving from $0.58 Billion in 2023 to $1.55 Billion in 2033.
- North America is largest regional market; Middle East and Africa is regional market region based on implied CAGR across 2023 to 2033.
- Europe and Asia Pacific show notable expansion: Europe grows from $0.43 Billion to $1.16 Billion, Asia Pacific from $0.28 Billion to $0.74 Billion.
- Key vendors include Illumina, Inc., Thermo Fisher Scientific Inc., Qiagen N.V., and Agilent Technologies, Inc., reflecting a concentrated supplier landscape.
Mirna Sequencing And Assay Market Report — Executive Summary
Regional analysis shows North America as largest market and Middle East and Africa as fastest-growing region by implied CAGR. The Mirna Sequencing And Assay market is undergoing sustained expansion driven by demand for precise molecular tools and enhanced research funding. Market value grows from $1.50 Billion in 2023 to $4.03 Billion by 2033 at a 10% CAGR over the 2023 to 2033 horizon. Technological innovation in sequencing platforms, broader adoption in diagnostics and therapeutics, and the need for sensitive assays are core growth enablers. Regionally, North America reports the largest absolute market, while Middle East and Africa record the most rapid rise. Product categories encompass sequencing kits, assay kits, and professional services; end users include academic and research institutes, pharma and biotech firms, diagnostic laboratories, and agricultural research organizations. Competitive activity centers on established life-sciences firms such as Illumina, Inc., Thermo Fisher Scientific Inc., Qiagen N.V., and Agilent Technologies, Inc. Ongoing emphasis on data accuracy, throughput, and bioinformatics integration will continue to shape product development and market adoption.
Key Growth Drivers
- Advances in sequencing platforms and assay sensitivity increasing capability and adoption across research and clinical settings.
- Expanded research funding and initiatives focusing on molecular biomarkers supporting broader use of miRNA tools.
- Rising applications in diagnostics and therapeutic discovery driving demand from pharmaceutical and biotechnology companies.
- Growing deployment in agricultural and plant research expanding non-clinical market segments.
- Demand for high-throughput solutions and integrated bioinformatics fueling kit and services uptake.
| Metric | Value |
|---|---|
| Study Period | 2023 - 2033 |
| 2023 Market Size | $1.50 Billion |
| CAGR (2023-2033) | 10% |
| 2033 Market Size | $4.03 Billion |
| Top Companies | Illumina, Inc., Thermo Fisher Scientific Inc., Qiagen N.V., Agilent Technologies, Inc. |
| Published Date | 14 October 2024 |
| Last Modified Date | 28 May 2026 |
Mirna Sequencing And Assay Market Overview
Customize Mirna Sequencing And Assay Market Report market research report
- ✔ Get in-depth analysis of Mirna Sequencing And Assay market size, growth, and forecasts.
- ✔ Understand Mirna Sequencing And Assay's regional dynamics and industry-specific trends.
- ✔ Identify potential applications, end-user demand, and growth segments in Mirna Sequencing And Assay
What is the Market Size & CAGR of Mirna Sequencing And Assay Market Report market in 2023?
Mirna Sequencing And Assay Industry Analysis
Mirna Sequencing And Assay Market Segmentation and Scope
Tell us your focus area and get a customized research report.
Mirna Sequencing And Assay Market Report Market Analysis Report by Region
Europe Mirna Sequencing And Assay Market Report:
Europe grows from $0.43 Billion in 2023 to $1.16 Billion in 2033. Expansion reflects increasing research initiatives, clinical applications of miRNA assays, and investment in sequencing platforms across academic and commercial labs.Asia Pacific Mirna Sequencing And Assay Market Report:
Asia Pacific grows from $0.28 Billion in 2023 to $0.74 Billion in 2033. Growth drivers include rising research activity, expanding diagnostic applications, and greater adoption of sequencing technologies in both clinical and agricultural research.North America Mirna Sequencing And Assay Market Report:
North America is largest regional market, rising from $0.58 Billion in 2023 to $1.55 Billion in 2033. Regional strength is tied to established research infrastructure, clinical diagnostics adoption, and procurement by pharmaceutical and biotechnology companies.South America Mirna Sequencing And Assay Market Report:
Latin America grows from $0.14 Billion in 2023 to $0.37 Billion in 2033. Regional uptake is influenced by growing research programs, diagnostic lab expansion, and increased interest in agricultural and plant miRNA applications.Middle East & Africa Mirna Sequencing And Assay Market Report:
Middle East and Africa is fastest-growing region by implied CAGR, increasing from $0.07 Billion in 2023 to $0.2 Billion in 2033. Growth is propelled by expanding research capacity, emerging clinical diagnostics demand, and investment in laboratory infrastructure.Tell us your focus area and get a customized research report.
Research Methodology
Mirna Sequencing And Assay Market Analysis By Product
In 2023, the Sequencing Kits segment accounted for $0.91 billion, which is 60.87% of the market share, projected to grow to $2.45 billion by 2033. Assay Kits hold $0.41 billion, marking 27.03% share, expected to reach $1.09 billion. Services constitute $0.18 billion contributing to a 12.1% share, anticipating growth to $0.49 billion.
Mirna Sequencing And Assay Market Analysis By Application
Diagnostics, with a market share of 53.56% worth $0.80 billion, is expected to reach $2.16 billion by 2033, while Research holds a share of 23.45% at $0.35 billion, projected to grow to $0.94 billion. The Therapeutics application segment, currently at 11.86% ($0.18 billion), will grow to $0.48 billion by 2033.
Mirna Sequencing And Assay Market Analysis By End User
The Academic and Research Institutes segment is valued at $0.73 billion, comprising 48.9%, projected to reach $1.97 billion by 2033. Pharmaceutical and Biotechnology Companies currently at 20.03% ($0.30 billion) will grow to $0.81 billion. Diagnostic Laboratories hold 10.07% ($0.15 billion), and Agriculture and Plant Research Companies occupy a share of 10.04% ($0.15 billion).
Mirna Sequencing And Assay Market Analysis By Technology
Next-Generation Sequencing (NGS) dominates the sector with a $0.91 billion share, approximately 60.87%, with projections to increase to $2.45 billion by 2033. Microarray technology, holding $0.41 billion (27.03%) is expected to reach $1.09 billion. Polymerase Chain Reaction (PCR), valued at $0.18 billion (12.1%), will expand to $0.49 billion.
Mirna Sequencing And Assay Market Analysis By Region Applications
Excluding specific applications, the regional segmentation indicates that North America leads the market with significant share and is expected to contribute the highest in market growth, while Europe follows with prominent growth initiatives. Asia-Pacific presents opportunities as investments in biotechnology research are growing, often overshadowed by North America's established market.
Mirna Sequencing And Assay Market Trends and Future Forecast
Tell us your focus area and get a customized research report.
Global Market Leaders and Top Companies in Mirna Sequencing And Assay Industry
Illumina, Inc.:
Illumina, Inc. is a frontrunner in sequencing technology and genomics, providing advanced platforms and reagents for miRNA analysis coupled with bioinformatics solutions, thereby enhancing research and application development.Thermo Fisher Scientific Inc.:
Thermo Fisher Scientific is a renowned biotechnology company offering a range of advanced miRNA assays and sequencing kits, playing a crucial role in facilitating genomic research and diagnostics globally.Qiagen N.V.:
Qiagen N.V. specializes in molecular diagnostics and is known for its cutting-edge solutions for miRNA extraction and analysis, significantly impacting clinical diagnosis and therapeutic applications.Agilent Technologies, Inc.:
Agilent Technologies provides a portfolio of miRNA analysis solutions and genomics technologies, with a focus on enhancing research efficiency and accuracy in the detection of miRNAs.We're grateful to work with incredible clients.
FAQs
What is the market size of the Mirna Sequencing And Assay market in 2023?
The Mirna Sequencing And Assay market size in 2023 is $1.50 Billion, as reported for the base year of the 2023 to 2033 forecast period.
How big will the market be by 2033?
By 2033 the market is projected to reach $4.03 Billion, according to the provided forecast covering 2023 to 2033.
What is CAGR for the 2023 to 2033 forecast period?
The market is projected to expand at a compound annual growth rate (CAGR) of 10% across the 2023 to 2033 period.
Which region is the fastest Growing in the Mirna Sequencing And Assay Market Report market?
Middle East and Africa is the fastest-growing region, projected to expand from $0.07 Billion in 2023 to $0.2 Billion in 2033, reflecting an implied 11.07% CAGR over the forecast period.
Which region is the fastest Growing?
Middle East and Africa is the regional market region, rising from $0.07 Billion in 2023 to $0.2 Billion in 2033 with an implied 11.07% CAGR.
Who are the top companies operating in the market?
Top companies named in the input include Illumina, Inc., Thermo Fisher Scientific Inc., Qiagen N.V., and Agilent Technologies, Inc., representing major market participants.
What product categories are included in the market segmentation?
Product segmentation comprises sequencing kits, assay kits, and services as listed in the provided sub segments for by-product.
How are end users categorized in this market?
End users include academic and research institutes, pharmaceutical and biotechnology companies, diagnostic laboratories, agriculture and plant research companies, and others, per input segments.